INTRODUCTION
Sickle cell anemia (SS disease)' is associated with abnormalities of the red cell membrane and decreased red cell deformability (1) (2) (3) (4) . An increase in membranebound hemoglobin is associated with SS disease cells (1, 2) . The role of the membrane-associated hemoglobin in SS disease in shortening the life-span of the red blood cells has not been characterized. In patients with sickle cell trait (AS disease), the red blood cell deformability may also be decreased (4) and red cell survival shortened in experimental models (5) . The present study was undertaken to assess the role of individual globin chains in the pathogenesis of abnormalities of the membrane of SS and AS cells. The 'Abbreviations used in this paper: AA, nonsickling; AS disease, sickle cell trait; CM-cellulose, carboxymethyl cellulose; SS disease, sickle cell anemia; S-thalassemia, sickle cell thalassemia. bound to the stroma in patients with both SS and AS disease.
METHODS
Heparinized blood was collected from patients with SS, AS, sickle cell-thalassemia (S-thalassemia) and nonsickling (AA) hemolytic disorders associated with AA hemoglobin.
The plasma was removed at 2,000 rpm for 10 min, and the cells were washed twice with normal saline. 1 Table I ). In the studies of AS patients, ["C]hemolysates from SS and AA patients were mixed and used as labeled carrier. The 'H incorporations in (,A+ p')/a were corrected by using the relative recovery of "C incorporations in (pA + pS)/a. The relative recovery of [1"C] 8A and -,P' did not vary significantly. Globin chain chromatography was performed by using a modification of the method originally described by Clegg, Naughton, and Weatherall (7, 8) . Aliquots of fractions collected from carboxymethyl cellulose (CM-cellulose) chromatography were counted in 1 Globin chromatography of supernate and stroma obtained from AS patient 1 (Table II) were examined in six patients with AA reticulocytoses (Table I ). In three of the six patients (patients 1, 2, and 5, Table I ), there is no increase in the relative amount of pA compared to a chains bound to stroma. In two patients (patients 4 and 6, Table I), there is a modest increase in the relative amount of pA compared to a globin (f'/a) bound to stroma as compared to that present in the supernate. In patient 3, Table I , there is a marked increase in the PA/a bound to stroma compared to that in supernate. There is no statistically significant difference in the #A/a ratios in supernate and stroma of the AA patients as a group (P > 0.20). The percent of AA counts bound to stroma compared to the total pA present varies from 1.3-8% and was greatest in patients 3 and 4, respectively. Similar studies were performed on five patients with SS disease (Table I ). The average increase in fi/a bound to stroma as compared to supernate is 2.5-fold, significantly higher than that in the AA patients (Table I ). The range is between 1.7-and 4.5-fold. The increase in the P'/a globin in stroma compared to supernate is significant at the 0.1% level (P < 0.001). Between 9.4 and 15% of the total P' present in the cells is bound to stroma. The 8H-labeled stroma of AA patients gave no significant radioactivity in the PA region; similarly, 8H-labeled stroma of SS patients gave no significant radioactivity in the PA region from CMcellulose chromatography.
Binding of globin chains to stroma in patients with AS disease. In four patients studied with AS disease (Table II, Fig. 1) , there is also a significant increase in the relative amount of total P compared to a globin ( [pA + #']/a) present in the stroma as compared to that in the supernate (P <0.01). While there is relatively balanced ([pA + P']/a) synthesis in the supernate of these four patients, there is a 1.8-to 2.2-fold increase in the relative amount of total P globin associated with stroma compared to a globin (Table II) . The increase in total P counts bound to stroma in the reticulocytes of these patients is preferentially an increase in P counts associated with stroma (Table II) supernate and stroma expressed as percent of total globin cpm is similar, while the percent of total globin cpm in stroma which are As counts is increased between 1.4-and 2.4-fold (Table II) . The relative increase in P8 over pA in stroma as compared to supernate is statistically significant (P < 0.01). In two patients with S-thalassemia (Table II) , there is also a relative increase in total P counts per a counts in stroma as compared to those in the supernate. In one of these patients, this increase appears to be due preferentially to binding of P3 globin, while in the other, both p8 and P8 counts bind to stroma. In the AS and S-thalassemia patients, the percent of P8 bound to stroma is between 5 and 15%.
DISCUSSION
In this study, the binding of newly synthesized globin chains to stroma has been studied by comparing the relative amounts of labeled globin chains present in the supernate with globin chains associated with red cell stroma. Although there is some variability in pA binding to AA stroma, there is no statistically significant preferential pA binding. By contrast, there is a significant increase in the amount of As globin relative to a globin bound to stroma in AS, SS, and S-thalassemia patients. Patients with AS were examined in order to control for differences between SS and AA cells. In AS patients, both pA and p8 chains are synthesized in the same cells.
In the four AS patients studied, the 
